PT102642B - Composicao farmaceutica de dosagem unica diaria contendo brivudine - Google Patents

Composicao farmaceutica de dosagem unica diaria contendo brivudine

Info

Publication number
PT102642B
PT102642B PT102642A PT10264201A PT102642B PT 102642 B PT102642 B PT 102642B PT 102642 A PT102642 A PT 102642A PT 10264201 A PT10264201 A PT 10264201A PT 102642 B PT102642 B PT 102642B
Authority
PT
Portugal
Prior art keywords
pharmaceutical
dosage containing
pharmaceutical composition
unique dosage
containing brivudine
Prior art date
Application number
PT102642A
Other languages
English (en)
Portuguese (pt)
Other versions
PT102642A (pt
Inventor
Alessandro Casini
Bettina Stubinski
Attilio Crea
Original Assignee
Berlin Chemie Ag
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin Chemie Ag, Menarini Ricerche Spa filed Critical Berlin Chemie Ag
Publication of PT102642A publication Critical patent/PT102642A/pt
Publication of PT102642B publication Critical patent/PT102642B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT102642A 2001-01-03 2001-07-05 Composicao farmaceutica de dosagem unica diaria contendo brivudine PT102642B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI000009A ITMI20010009A1 (it) 2001-01-03 2001-01-03 Composizioni farmaceutica contenente brivudina per la singola somministrazione giornaliera

Publications (2)

Publication Number Publication Date
PT102642A PT102642A (pt) 2002-07-31
PT102642B true PT102642B (pt) 2003-06-30

Family

ID=11446384

Family Applications (1)

Application Number Title Priority Date Filing Date
PT102642A PT102642B (pt) 2001-01-03 2001-07-05 Composicao farmaceutica de dosagem unica diaria contendo brivudine

Country Status (20)

Country Link
AT (1) AT6141U1 (sk)
BE (1) BE1014522A5 (sk)
CH (1) CH695662A5 (sk)
CZ (1) CZ20012464A3 (sk)
DK (1) DK177084B1 (sk)
ES (1) ES2192456B1 (sk)
FI (1) FI20011446A (sk)
FR (1) FR2818907B1 (sk)
GB (1) GB2370771A (sk)
GR (1) GR1004012B (sk)
HR (1) HRPK20010345B3 (sk)
HU (1) HUP0102816A3 (sk)
IE (1) IE20010413A1 (sk)
IT (1) ITMI20010009A1 (sk)
NL (1) NL1018431C2 (sk)
PL (1) PL348480A1 (sk)
PT (1) PT102642B (sk)
SE (1) SE0102309L (sk)
SK (1) SK287043B6 (sk)
UA (1) UA76402C2 (sk)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239527B1 (es) * 2004-03-01 2006-11-16 M. Cruz Fernandez Gonzalez Composicion farmacologica de uso topico para el tratamiento del herpes zoster.
CN113712928A (zh) * 2021-09-29 2021-11-30 重庆市力扬医药开发有限公司 经口腔粘膜吸收的溴夫定药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104857A1 (en) * 1982-09-28 1984-04-04 Beecham Group Plc Deoxyuridine compounds, methods for preparing them and their use in medicine
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
US5446031A (en) * 1991-04-24 1995-08-29 Yamasa Shuyu Kabushiki Kaisha 1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
DK0874631T3 (da) * 1996-01-19 2004-03-22 Glaxo Group Ltd Anvendelse af valaciclovir til fremstilling af et medikament til behandling af genital herpes ved en enkelt daglig anvendelse

Also Published As

Publication number Publication date
FI20011446A (fi) 2002-07-04
UA76402C2 (en) 2006-08-15
SE0102309L (sv) 2002-07-04
HUP0102816A2 (en) 2002-10-28
BE1014522A5 (fr) 2003-12-02
ITMI20010009A0 (it) 2001-01-03
DK177084B1 (da) 2011-07-11
SE0102309D0 (sv) 2001-06-28
CH695662A5 (de) 2006-07-31
AT6141U1 (de) 2003-05-26
NL1018431C2 (nl) 2002-07-05
GR1004012B (el) 2002-11-01
DK200101019A (da) 2002-07-04
PL348480A1 (en) 2002-07-15
SK287043B6 (sk) 2009-10-07
GB0110682D0 (en) 2001-06-20
HRPK20010345B3 (en) 2005-02-28
GB2370771A (en) 2002-07-10
ES2192456A1 (es) 2003-10-01
FR2818907B1 (fr) 2006-05-26
FI20011446A0 (fi) 2001-07-03
FR2818907A1 (fr) 2002-07-05
HU0102816D0 (en) 2001-09-28
GR20010100322A (el) 2002-10-08
HRP20010345A2 (en) 2003-08-31
IE20010413A1 (en) 2003-04-16
CZ20012464A3 (cs) 2002-08-14
HUP0102816A3 (en) 2005-01-28
PT102642A (pt) 2002-07-31
ITMI20010009A1 (it) 2002-07-03
ES2192456B1 (es) 2005-02-01
SK9572001A3 (en) 2003-03-04

Similar Documents

Publication Publication Date Title
ATE296619T1 (de) Feste orale dosierungsform von simethicon
PT1066027E (pt) Composicao farmaceutica de topiramato
FI20011478A0 (fi) Farmaseuttinen koostumus
IS6986A (is) Lyfjasamsetning í vökvaformi
PL367180A1 (en) Stabilized oral pharmaceutical composition
HRP20030873A2 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylatoe having such element
PT1235799E (pt) Forma polimorfica de atorvastatina-calcio
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
DK1674084T3 (da) Forlænget frigivelse af oral dosissammensætning
EE05020B1 (et) Glburiidi ravimkoostis
PT1458377E (pt) Composicoes farmaceuticas contendo tegaserod
BRPI0209720A2 (pt) dosagem e embalagem de medicação com liberação controlada
EE200300589A (et) Ravimkoostised
FI20022128A0 (fi) Farmaseuttinen koostumus
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
ATE324883T1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
NO20021898D0 (no) Farmasöytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine
HUP0401862A3 (en) Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them
PT102642A (pt) Composicao farmaceutica de dosagem unica diaria contendo brivudine
ITBO20010005V0 (it) Distributore automatico di medicinali
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 20030514